☰

Susan R. Atlas - Publications

Affiliations: 
Biomedical Sciences University of New Mexico, Albuquerque, NM, United States 
Area:
Genetics, Computer Science, Biostatistics Biology, Bioinformatics Biology
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Edwards JS, Atlas SR, Wilson SM, Cooper CF, Luo L, Stidley CA. Integrated statistical and pathway approach to next-generation sequencing analysis: a family-based study of hypertension. Bmc Proceedings. 8: S104. PMID 25519358 DOI: 10.1186/1753-6561-8-S1-S104  0.32
2013 Urtishak KA, Edwards AY, Wang LS, Hudome A, Robinson BW, Barrett JS, Cao K, Cory L, Moore JS, Bantly AD, Yu QC, Chen IM, Atlas SR, Willman CL, Kundu M, et al. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood. 121: 2689-703. PMID 23393050 DOI: 10.1182/Blood-2012-04-425033  0.313
2013 Harvey RC, Kang H, Roberts KG, Chen IL, Atlas SR, Bedrick EJ, Gastier-Foster JM, Zhang J, Gerhard DS, Smith MA, Larsen EC, Raetz EA, Winick NJ, Carroll WL, Stonerock E, et al. Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (“Ph-like” or “BCR-ABL1-Like”) Signature For Therapeutic Targeting and Clinical Intervention Blood. 122: 826-826. DOI: 10.1182/Blood.V122.21.826.826  0.415
2013 Li-San W, Teachey DT, Sarah TK, Barrett JS, Chen IL, Atlas SR, Harvey RC, Heerema NA, Carroll AJ, Hunger SP, Willman CL, Felix CA. PI3K/AKT/mTOR Signaling Is a Significant Druggable Pathway In Infant Acute Lymphoblastic Leukemia (ALL) Blood. 122: 1669-1669. DOI: 10.1182/Blood.V122.21.1669.1669  0.357
2012 Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW, Valsecchi MG, Pieters R, Heerema NA, Hilden JM, et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 119: 1872-81. PMID 22210879 DOI: 10.1182/Blood-2011-10-382861  0.404
2011 Ho A, Murphy M, Wilson S, Atlas SR, Edwards JS. Sequencing by ligation variation with endonuclease V digestion and deoxyinosine-containing query oligonucleotides. Bmc Genomics. 12: 598. PMID 22151854 DOI: 10.1186/1471-2164-12-598  0.448
2010 Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 116: 4874-84. PMID 20699438 DOI: 10.1182/Blood-2009-08-239681  0.569
2010 Kang H, Chen IM, Wilson CS, Bedrick EJ, Harvey RC, Atlas SR, Devidas M, Mullighan CG, Wang X, Murphy M, Ar K, Wharton W, Borowitz MJ, Bowman WP, Bhojwani D, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 115: 1394-405. PMID 19880498 DOI: 10.1182/blood-2009-05-218560  0.522
2010 Kang H, Wilson CS, Harvey RC, Chen I, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Heerema NA, Hilden JM, Dreyer ZE, Camitta B, Winick N, et al. Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study Blood. 116: 412-412. DOI: 10.1182/Blood.V116.21.412.412  0.42
2010 Urtishak KA, Wang L, Harvey R, Atlas SR, Chen IL, Robinson BW, Moukarzel L, Cao K, Devidas M, Carroll AJ, Heerema NA, Hunger S, Reaman GH, Hilden JM, Camitta B, et al. Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL-ENL, and gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial Blood. 116: 2757-2757. DOI: 10.1182/Blood.V116.21.2757.2757  0.398
2009 Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, Phillips LA, Tasian SK, Loh ML, Su X, Liu W, Devidas M, Atlas SR, Chen IM, Clifford RJ, Gerhard DS, et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 106: 9414-8. PMID 19470474 DOI: 10.1073/Pnas.0811761106  0.333
2008 Zhang AY, Robinson BW, Wang L, Kao K, Cory L, Barrett JS, Atlas S, Chen I, Harvey RC, Willman CL, Devidas M, Carroll AJ, Hunger SP, Moore JS, Thompson CB, et al. Pan-Anti-Apoptotic BCL-2 Family Inhibitor, Obatoclax, Activates Autophagic Cell Death Pathway and Has Potent Cytotoxicity in Infant and Pediatric MLL-Rearranged Leukemias Blood. 112: 2647-2647. DOI: 10.1182/Blood.V112.11.2647.2647  0.398
2007 Andries E, Hagstrom T, Atlas SR, Willman C. Regularization strategies for hyperplane classifiers: application to cancer classification with gene expression data. Journal of Bioinformatics and Computational Biology. 5: 79-104. PMID 17477492 DOI: 10.1142/S0219720007002539  0.354
2007 Martin SB, Mosquera-Caro MP, Potter JW, Davidson GS, Andries E, Kang H, Helman P, Veroff RL, Atlas SR, Murphy M, Wang X, Ar K, Xu Y, Chen IM, Schultz FA, et al. Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia. Leukemia. 21: 1341-4. PMID 17410195 DOI: 10.1038/Sj.Leu.2404640  0.516
2007 Zeng W, Chen I, Tibbitts J, Kang H, Ar K, Atlas S, Willman CL. Expression of Midkine(MDK) and Sensitivity to Anti-Leukemic Drugs in Pediatric Acute Lymphoblastic Leukemia (ALL). Blood. 110: 1432-1432. DOI: 10.1182/Blood.V110.11.1432.1432  0.378
2007 Harvey RC, Davidson GS, Wang X, Dobbin KK, Bedrick EJ, Wilson CS, Atlas SR, Kang H, Chen I, Hunger SP, Devidas M, Carroll WL, Bowman P, Camitta B, Reaman G, et al. Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study. Blood. 110: 1430-1430. DOI: 10.1182/Blood.V110.11.1430.1430  0.561
2006 Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R, Ar K, Xu Y, Kopecky KJ, Ankerst DP, Gundacker H, Slovak ML, Mosquera-Caro M, Chen IM, Stirewalt DL, ... ... Atlas SR, et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood. 108: 685-96. PMID 16597596 DOI: 10.1182/Blood-2004-12-4633  0.558
2005 Willman CL, Kang H, Potter JW, Harvey RC, Atlas SR, Bedrick E, Helman P, Veroff RL, Chen I, Carroll AJ, Ar K, Xu Y, Murphy SB, Bhojwani D, Moskowitz N, et al. A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL). Blood. 106: 762-762. DOI: 10.1182/Blood.V106.11.762.762  0.485
2004 Helman P, Veroff R, Atlas SR, Willman C. A Bayesian network classification methodology for gene expression data. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 11: 581-615. PMID 15579233 DOI: 10.1089/Cmb.2004.11.581  0.319
Show low-probability matches.